Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (N05Ax13) And The Trade Name Trevicta® As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 95312356

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient paliperidone (N05AX13) and the trade name Trevicta® within the p eriod from December 1, 2024 to November 30, 2026 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list in accordance with Section 35 Paragraph 5a SGB V (medicines for children) are excluded.notice_title: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Contai

Gt Ref Id - 95312356

Deadline - Sep 30, 2026